Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery

Publisher Website
Google Scholar
Abstract
We have studied the effects of three βAR ligands (carvedilol, alprenolol, and ICI‐118,551) with different pharmacological profiles and negative efficacy at the β2AR on cardiac in vivo, in vitro, biochemical and gene expression parameters in mice with permanent occlusion of the left anterior descending coronary artery. Cardiac in vivo parameters were determined using Doppler studies. Mitral‐wave E peak velocity (EPV) and aortic peak velocity (AoPV) decreased in the first 2 weeks postocclusion. After 3 weeks of drug treatment, EPV was improved in the carvedilol group to preocclusion values; however, a further reduction in EPV in the alprenolol and control permanent occlusion group was measured and there was no change after ICI‐118,551 treatment. AoPV was unchanged between weeks 2 and 5 in all groups. The left atria were isolated to record isometric tension responses to isoprenaline. Permanent occlusion significantly reduced the maximum isoprenaline response to 30% of control and carvedilol increased the maximum response to isoprenaline significantly to 60%. The biochemical and gene expression studies revealed different effects of the three βAR ligands. Most notably, carvedilol reduced gene expression of myosin heavy chain β. These results indicate that chronic treatment with carvedilol is beneficial in a mouse model of myocardial damage resulting from ischaemia. We hypothesise that these beneficial effects of the drug may be because of the negative efficacy at the β2AR, combined with β1AR antagonism. British Journal of Pharmacology (2003) 138, 1505–1516. doi:10.1038/sj.bjp.0705205

This publication has 71 references indexed in Scilit: